Sadly NARI will farewell Professor Stephen Gibson at the end of June, who is leaving to pursue new directions. He will however remain as Honorary Professorial Fellow.
Stephen, Deputy Director of NARI and Director of the Clinical Research Division, has made an invaluable contribution to NARI over 30 years, leading internationally recognised research into pain, particularly into recognising and managing pain in people living with dementia.
Director Associate Professor Briony Dow said: “At NARI Stephen has supervised and mentored a whole generation of gerontology researchers, adding to the capacity of the sector, has been the go-to expert on methodology and contributed as part of the leadership team. His sage advice and corporate knowledge will be greatly missed in Executive and Board meetings.”
“Stephen is a strong advocate for relief of pain in older people through his research, publications and involvement on the International Pain Society,” she added.
Stephen is a registered psychologist and has been involved in ageing research for over 25 years. His current research interests include studies on pain assessment in persons with dementia, age differences in pain and its impacts, fMRI responses to pain, and the implementation of pain management guidelines into the residential aged care sector.
Stephen said "it is with genuine sadness that I am leaving NARI; the mission, activities and mostly importantly, my colleagues and friends, are simply outstanding. It has been my great privilege to be able to work with the NARI team over many years and to contribute to their professional development, as NARI has contributed to mine over my entire tenure. It has been a wonderful journey and I believe that our collective efforts have led to many major improvements in the day to day lives of older people, both in Australia and on the world stage. With an ageing population, the abundant skills and expertise at NARI are needed more now than ever before and I look forward to my continued involvement in its success as an honorary fellow."
He has been a principal chief investigator on funding grants from the NHMRC since 1994 and has attracted competitive grants totalling more than $15 million over his career. He was awarded the 2006 Pfizer International Visiting Professorship in pain medicine and a distinguished member award at the Australian Pain Society in 2016. He has contributed to more than 200 peer-reviewed publications, is on the editorial board of several leading scientific journals and is a sought after speaker at international meetings.
We wish him all the best for the future.